This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 23 Apr 2013  |  Global  |  Market Research

    Healthcare Landscape, Outlook, and Growth Opportunities in India

    The healthcare market in India is in a growth stage and the growth rate is as high as any other fast-growing markets in the country. Moreover, the healthcare market is expected to drive the economy in the coming years. The main factors driving the growth are rising population, change in demographics, rise in disposable income, change in disease pro...

    $4,950.00
  2. 09 Apr 2013  |  Global  |  Market Research

    The Future of Biopharmaceutical Contract Manufacturing in Europe - What Underpins the Success of CMOs?

    European Biopharmaceutical Contract Manufacturing Market

    This issue of Vital Signs, released in July 2015, discusses Affmetrix's acquisition of Eureka Genomics, OPKO Health's acquisition of Bio-Reference Laboratories, CVS Health's acquisition of Target's in-store pharmacies and clinics, and Thermo Fisher Scientific's acquisition of Alfa Aesar.

    $1,500.00
  3. 28 Mar 2013  |  Latin America  |  Market Research

    Brazilian Medical Imaging Market Outlook for CT, MRI, and Ultrasound

    Governmental Programs and Investments Stimulate the Market

    This study analyzes the Brazilian medical imaging market from 2011 to 2017, focusing exclusively on computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. The analyzed total market is expected to growth with a single-digit CAGR for 2012 to 2017. This growth rate is mainly driven by the C-class economic growth that allows increa...

    $10,000.00
  4. 26 Mar 2013  |  Global  |  Market Research

    Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS

    Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...

    $1,500.00
  5. 21 Mar 2013  |  Global  |  Market Research

    Strategic Analysis of Anti-obesity Prescription Drug Development

    Recent Marketing Approvals Revive Hope for Successful Treatment Options

    This research service focuses on prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided, along with additional supporting information, such as clinical trial timelines and results, historical and projected launch timeline...

    $1,500.00
  6. 22 Feb 2013  |  Global  |  Market Research

    Financial Assessment of the Global Pharmaceutical and Biotechnology Industry

    Financial Management is the Key Strategy for Sustainability

    This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on s...

    $4,950.00
  7. This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.

    $1,500.00
  8. This issue of Vital Signs, released in August 2015, discusses The Real Fight Against Cancer: The Struggle to make Drugs Affordable, OPKO Health's acquisition of Bio-Reference Laboratories, Health Insurance Company Mergers  How will Consumers Fare?, and Illumina's acquisition of GenoLogics.

    $1,500.00
  9. 25 Jan 2013  |  Global  |  Market Research

    GIL-100 Sales and Investment Attractiveness Index for Healthcare

    Country Attractiveness for Healthcare

    Where should one invest or sell in the aftermath of the financial crisis of 2008 and the on-going European debt crisis? While rich countries have shown very slow growth rates, emerging markets have shown much greater resilience. To increase profitability, you can either find new markets to increase sales, or seek opportunities to invest. Emerging ...

    $1,500.00